Filing Details
- Accession Number:
- 0001209191-21-058170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-30 15:56:58
- Reporting Period:
- 2021-09-28
- Accepted Time:
- 2021-09-30 15:56:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1802768 | Royalty Pharma Plc | RPRX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1016835 | B Rory Riggs | C/O Royalty Pharma Plc 110 E. 59Th Street New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Ordinary Shares | Disposition | 2021-09-28 | 40,000 | $36.75 | 639,760 | No | 4 | S | Direct | |
Class A Ordinary Shares | Disposition | 2021-09-29 | 24,648 | $36.50 | 615,112 | No | 4 | S | Direct | |
Class A Ordinary Shares | Acquisiton | 2021-09-29 | 2,334 | $0.00 | 617,446 | No | 4 | J | Direct | |
Class A Ordinary Shares | Acquisiton | 2021-09-29 | 5,299 | $0.00 | 622,745 | No | 4 | J | Direct | |
Class A Ordinary Shares | Acquisiton | 2021-09-29 | 8,641 | $0.00 | 631,386 | No | 4 | J | Direct | |
Class A Ordinary Shares | Disposition | 2021-09-29 | 34,604 | $36.31 | 899,306 | No | 4 | S | Indirect | By New Ventures Select |
Class A Ordinary Shares | Disposition | 2021-09-29 | 109,814 | $0.00 | 789,492 | No | 4 | J | Indirect | By New Ventures Select |
Class A Ordinary Shares | Disposition | 2021-09-29 | 22,173 | $36.31 | 3,429,085 | No | 4 | S | Indirect | By New Ventures I LLC |
Class A Ordinary Shares | Disposition | 2021-09-29 | 511,727 | $0.00 | 2,917,358 | No | 4 | J | Indirect | By New Ventures I LLC |
Class A Ordinary Shares | Disposition | 2021-09-29 | 7,000 | $36.67 | 2,074,540 | No | 4 | S | Indirect | By New Ventures III LLC |
Class A Ordinary Shares | Disposition | 2021-09-29 | 314,886 | $0.00 | 1,759,654 | No | 4 | J | Indirect | By New Ventures III LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | J | Direct | |
No | 4 | J | Direct | |
No | 4 | J | Direct | |
No | 4 | S | Indirect | By New Ventures Select |
No | 4 | J | Indirect | By New Ventures Select |
No | 4 | S | Indirect | By New Ventures I LLC |
No | 4 | J | Indirect | By New Ventures I LLC |
No | 4 | S | Indirect | By New Ventures III LLC |
No | 4 | J | Indirect | By New Ventures III LLC |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Ordinary Shares | LP interests in RPI US Partners 2019, LP | Disposition | 2021-09-10 | 7,692 | $0.00 | 76,920 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
534,059 | No | 5 | G | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Ordinary Shares | 15,000 | Indirect | By Spouse |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.58 to $36.96 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.15 to $36.87 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
- Pro rata distribution from New Ventures Select, of which the Reporting Person has voting and investment control.
- Pro rata distribution from a limited liability company of which the Reporting Person is a member.
- Pro rata distribution from New Ventures I LLC, of which the Reporting Person has voting and investment control.
- Pro rata distribution from New Ventures III LLC, of which the Reporting Person has voting and investment control.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $36.50 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- New Ventures Select distributed these shares to its members on a pro rata basis, for no consideration.
- New Ventures I LLC distributed these shares to its members on a pro rata basis, for no consideration.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.62 to $36.75 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- New Ventures III LLC distributed these shares to its members on a pro rata basis, for no consideration.
- No limited partnership interests in RPI US Partners 2019, LP ("RPI US LP") are being exchanged by the Reporting Person. Each limited partnership interest in RPI US LP ("RPI US LP Interest") may be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. Any exchanges will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with an exchange.
- The Reporting Person made a charitable donation of RPI US LP Interests. No Class A Ordinary Shares or RPI US LP Interests were sold.
- Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.